Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86


A functional TNFRSF5 polymorphism and risk of non-Hodgkin lymphoma, a pooled analysis.

Nieters A, Bracci PM, de Sanjosé S, Becker N, Maynadié M, Benavente Y, Foretova L, Cocco P, Staines A, Holly EA, Boffetta P, Brennan P, Skibola CF.

Int J Cancer. 2011 Mar 15;128(6):1481-5. doi: 10.1002/ijc.25420.


A functional TNFRSF5 gene variant is associated with risk of lymphoma.

Skibola CF, Nieters A, Bracci PM, Curry JD, Agana L, Skibola DR, Hubbard A, Becker N, Smith MT, Holly EA.

Blood. 2008 Apr 15;111(8):4348-54. doi: 10.1182/blood-2007-09-112144. Epub 2008 Feb 20.


No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma.

Havranek O, Spacek M, Hubacek P, Mocikova H, Benesova K, Soucek P, Trneny M, Kleibl Z.

Leuk Res. 2011 Aug;35(8):1117-9. doi: 10.1016/j.leukres.2011.04.001. Epub 2011 May 5.


The CD40 gene polymorphism rs1883832 is associated with risk of acute coronary syndrome in a Chinese case-control study.

Wang M, Li Y, Li W, Xia ZE, Wu Q.

DNA Cell Biol. 2011 Mar;30(3):173-8. doi: 10.1089/dna.2010.1129. Epub 2010 Nov 22.


Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.

Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, Engels EA, Davis S, Severson RK, Rothman N, Chanock SJ, Hartge P.

Cancer Res. 2007 May 15;67(10):5042-54.


Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.

Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, Turner J, Whitby D, Chanock S, Rothman N, Armstrong BK.

Carcinogenesis. 2007 Mar;28(3):704-12. Epub 2006 Oct 20.


The +252A/G polymorphism in the Lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: a meta-analysis.

Cao C, Liu S, Lou SF, Liu T.

Eur Rev Med Pharmacol Sci. 2014;18(4):544-52. Review.


Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.

Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willett E, De Sanjose S, Cocco P, Berndt SI, Brennan P, Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng T, Roman E, Holly EA, Boffetta P, Armstrong B, Cozen W, Linet M, Bosch FX, Ennas MG, Holford TR, Gallagher RP, Rollinson S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer B, Lai A, Spink C, Davis S, Bosch R, Scarpa A, Zhang Y, Severson RK, Yeager M, Chanock S, Nieters A.

Lancet Oncol. 2006 Jan;7(1):27-38.


Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.

Wang SS, Menashe I, Cerhan JR, Cozen W, Severson RK, Davis S, Hutchinson A, Rothman N, Chanock SJ, Bernstein L, Hartge P, Morton LM.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):42-9. doi: 10.1158/1055-9965.EPI-10-0638. Epub 2010 Dec 10.


Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.

Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, Armstrong BK, Lan Q, Hartge P, Kricker A, Zhang Y, Morton LM, Vajdic CM, Holford TR, Severson RK, Grulich A, Leaderer BP, Davis S, Cozen W, Yeager M, Chanock SJ, Chatterjee N, Rothman N.

PLoS One. 2009;4(4):e5360. doi: 10.1371/journal.pone.0005360. Epub 2009 Apr 24.


Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.

Wang SS, Davis S, Cerhan JR, Hartge P, Severson RK, Cozen W, Lan Q, Welch R, Chanock SJ, Rothman N.

Carcinogenesis. 2006 Sep;27(9):1828-34. Epub 2006 Mar 16.


Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.

Hu W, Bassig BA, Xu J, Zheng T, Zhang Y, Berndt SI, Holford TR, Hosgood HD 3rd, Leaderer B, Yeager M, Menashe I, Boyle P, Zou K, Zhu Y, Chanock S, Lan Q, Rothman N.

Environ Mol Mutagen. 2013 Jan;54(1):72-7. doi: 10.1002/em.21739. Epub 2012 Oct 11.


Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.

Lan Q, Wang SS, Menashe I, Armstrong B, Zhang Y, Hartge P, Purdue MP, Holford TR, Morton LM, Kricker A, Cerhan JR, Grulich A, Cozen W, Zahm SH, Yeager M, Vajdic CM, Schenk M, Leaderer B, Yuenger J, Severson RK, Chatterjee N, Chanock SJ, Zheng T, Rothman N.

Br J Haematol. 2011 May;153(3):341-50. doi: 10.1111/j.1365-2141.2010.08424.x. Epub 2011 Mar 21.


Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.

Soucek P, Sarmanová J, Kristensen VN, Apltauerová M, Gut I.

Int Arch Occup Environ Health. 2002 Oct;75 Suppl:S86-92. Epub 2002 Jul 3.


Association between polymorphic sites in thymidylate synthase gene and risk of non-Hodgkin lymphoma: a systematic review and pooled analysis.

Zhou JY, Shi R, Yu HL, Zeng Y, Zheng WL, Ma WL.

Leuk Lymphoma. 2012 Oct;53(10):1953-60. doi: 10.3109/10428194.2012.673226. Epub 2012 Apr 23. Review.


Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.

Shen M, Zheng T, Lan Q, Zhang Y, Zahm SH, Wang SS, Holford TR, Leaderer B, Yeager M, Welch R, Kang D, Boyle P, Zhang B, Zou K, Zhu Y, Chanock S, Rothman N.

Hum Genet. 2006 Jul;119(6):659-68. Epub 2006 Apr 26.


Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.

Novik KL, Spinelli JJ, Macarthur AC, Shumansky K, Sipahimalani P, Leach S, Lai A, Connors JM, Gascoyne RD, Gallagher RP, Brooks-Wilson AR.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1098-106.


C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.

Song H, Tong D, Cha Z, Bai J.

Mol Biol Rep. 2012 Sep;39(9):8629-35. doi: 10.1007/s11033-012-1717-6. Epub 2012 Jun 17.


One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.

Lee KM, Lan Q, Kricker A, Purdue MP, Grulich AE, Vajdic CM, Turner J, Whitby D, Kang D, Chanock S, Rothman N, Armstrong BK.

Hum Genet. 2007 Dec;122(5):525-33. Epub 2007 Sep 21.


Human leukocyte antigens and genetic susceptibility to lymphoma.

McAulay KA, Jarrett RF.

Tissue Antigens. 2015 Aug;86(2):98-113. doi: 10.1111/tan.12604. Review.


Supplemental Content

Support Center